Trending stocks

China Child Care Corp Ltd Net Income dropped on 125% in 2015 and EBITDA Margin dropped on 16.6 pp from 14.2% to -2.4%

29/03/2016 • About China Child Care Corp Ltd ($1259) • By InTwits

China Child Care Corp Ltd reported 2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • China Child Care Corp Ltd doesn't have a profitable business model yet: 2015 ROIC is -3.6%
  • EBITDA Margin is declining: -2.4% in 2015 vs. 14.2% in 2014 vs. 18.3% in 2011
  • EBITDA Margin is quite volatile: -2.4% in 2015, 14.2% in 2014, 18.6% in 2013, 19.4% in 2012, 18.3% in 2011
  • China Child Care Corp Ltd has medium CAPEX intensity: 5 year average CAPEX/Revenue was 5.6%. At the same time it's a lot of higher than industry average of 7.5%.
  • CAPEX is quite volatile: 23.3 in 2015, 116 in 2014, 173 in 2013, 41.9 in 2012, 58.1 in 2011
  • The company has unprofitable business model: ROIC is at -3.6%
  • It operates with high leverage: Net Debt/EBITDA is 3.6x while industry average is -1.1x
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

China Child Care Corp Ltd ($1259) key annual financial indicators

mln. CNY201120122013201420152015/2014
P&L
Revenue1,2691,5721,7121,482914-38.4%
Gross Profit538722810705359-49.0%
SG&A320434513513415-19.0%
EBITDA232306318210-22-110.4%
Net Income184241200200-50-125.1%
Balance Sheet
Cash7366438599679690.2%
Short Term Debt3000050
Long Term Debt00000
Cash flow
Capex584217311623-79.9%
Ratios
Revenue growth51.5%23.9%8.9%-13.4%-38.4%
EBITDA growth33.4%31.9%4.0%-33.9%-110.4%
Gross Margin42.4%45.9%47.3%47.5%39.3%-8.2%
EBITDA Margin18.3%19.4%18.6%14.2%-2.4%-16.6%
Net Income Margin14.5%15.3%11.7%13.5%-5.5%-19.0%
SG&A, % of revenue25.2%27.6%29.9%34.6%45.5%10.9%
CAPEX, % of revenue4.6%2.7%10.1%7.8%2.6%-5.3%
ROIC38.8%27.2%23.9%13.4%-3.6%-17.0%
ROE33.6%22.9%16.1%14.3%-3.5%-17.7%
Net Debt/EBITDA-3.0x-2.1x-2.7x-4.6x4.6x

Revenue and profitability


The company's Revenue dropped on 38.4% in 2015. Revenue decline was accompanies by EBITDA margin decline. EBITDA Margin dropped on 16.6 pp from 14.2% to -2.4% in 2015.

Gross Margin decreased on 8.2 pp from 47.5% to 39.3% in 2015. SG&A as a % of Revenue jumped on 10.9 pp from 34.6% to 45.5% in 2015.

Net Income marign dropped on 19.0 pp from 13.5% to -5.5% in 2015.

Capital expenditures (CAPEX) and working capital investments


In 2015 the company had CAPEX/Revenue of 2.6%. China Child Care Corp Ltd's CAPEX/Revenue showed almost no change from 2012 to 2015. For the last three years the average CAPEX/Revenue was 6.8%.

Return on investment


The company operates at negative ROIC (-3.61%) and ROE (-3.47%). ROIC dropped on 17.0 pp from 13.4% to -3.6% in 2015. ROE dropped on 17.7 pp from 14.3% to -3.5% in 2015.

Leverage (Debt)


Debt level is 3.6x Net Debt / EBITDA and Debt / EBITDA. Net Debt / EBITDA jumped on 4.6x from -4.6x to in 2015. Debt surged while cash showed almost no change in 2015.

Appendix 1: Peers in Cosmetics/Personal Care


Below you can find China Child Care Corp Ltd benchmarking vs. other companies in Cosmetics/Personal Care industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Rui Kang Pharmaceutical Group Investments Ltd ($8037)-5.0%-20.2%-24.8%117.2%
EDS Wellness Holdings Ltd ($8176)-98.6%1,059.5%238.8%70.4%
Vinda International Holdings Ltd ($3331)26.4%12.8%17.5%21.4%
L'Occitane International SA ($973)18.3%14.2%1.1%11.7%
Ming Fai International Holdings Ltd ($3828)14.3%-0.1%-3.4%5.2%
 
Median (7 companies)-5.0%-0.1%1.1%11.7%
China Child Care Corp Ltd ($1259)23.9%8.9%-13.4%-38.4%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
L'Occitane International SA ($973)82.5%82.7%82.0%81.1%81.8%
Natural Beauty Bio-Technology Ltd ($157)79.3%78.6%75.8%76.9%78.4%
BaWang International Group Holding Ltd ($1338)38.8%41.9%48.5%37.4%38.0%
Vinda International Holdings Ltd ($3331)27.2%30.8%29.0%30.2%30.5%
Ming Fai International Holdings Ltd ($3828)21.9%21.6%23.9%24.0%24.4%
 
Median (6 companies)33.0%36.4%38.7%38.6%34.3%
China Child Care Corp Ltd ($1259)42.4%45.9%47.3%47.5%39.3%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Natural Beauty Bio-Technology Ltd ($157)31.4%38.3%25.3%29.4%38.7%
Rui Kang Pharmaceutical Group Investments Ltd ($8037)17.1%9.5%-23.3%-37.4%20.4%
L'Occitane International SA ($973)20.9%20.7%19.3%17.4%19.6%
Vinda International Holdings Ltd ($3331)13.9%16.1%14.2%15.3%13.7%
Ming Fai International Holdings Ltd ($3828)8.0%8.0%7.4%8.6%11.5%
 
Median (7 companies)13.9%9.5%7.4%8.6%13.7%
China Child Care Corp Ltd ($1259)18.3%19.4%18.6%14.2%-2.4%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
EDS Wellness Holdings Ltd ($8176)0.4%387.3%119.7%14.9%34.3%
Vinda International Holdings Ltd ($3331)16.2%20.5%20.2%12.9%12.4%
Natural Beauty Bio-Technology Ltd ($157)8.6%10.1%5.1%3.7%12.0%
Ming Fai International Holdings Ltd ($3828)5.5%1.8%1.4%2.3%7.5%
L'Occitane International SA ($973)4.7%6.2%7.6%5.8%4.3%
 
Median (7 companies)5.5%10.1%6.6%3.7%7.5%
China Child Care Corp Ltd ($1259)4.6%2.7%10.1%7.8%2.6%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Rui Kang Pharmaceutical Group Investments Ltd ($8037)60.3%17.7%-67.7%-113.8%35.6%
Natural Beauty Bio-Technology Ltd ($157)20.2%19.4%9.2%13.6%20.7%
L'Occitane International SA ($973)31.6%23.2%21.4%16.9%19.6%
Ming Fai International Holdings Ltd ($3828)6.9%7.2%4.3%5.6%12.0%
Vinda International Holdings Ltd ($3331)11.4%13.8%10.4%10.0%9.0%
 
Median (7 companies)11.4%13.8%4.3%5.6%12.0%
China Child Care Corp Ltd ($1259)38.8%27.2%23.9%13.4%-3.6%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Vinda International Holdings Ltd ($3331)1.9x1.4x2.1x3.1x3.3x
Ming Fai International Holdings Ltd ($3828)-1.2x-1.5x-2.5x-2.1x-1.2x
L'Occitane International SA ($973)-1.5x-1.3x-1.2x-1.3x-1.2x
Natural Beauty Bio-Technology Ltd ($157)-3.0x-2.3x-4.6x-3.9x-2.6x
Rui Kang Pharmaceutical Group Investments Ltd ($8037)-1.5x-1.9x-3.8x
 
Median (5 companies)-1.5x-1.5x-1.8x-1.7x-1.2x